Streetbeat News

Analyst Ratings

LOB

Truist Securities analyst Jennifer Demba maintains a 'Buy' rating on Live Oak Bancshares (NYSE:LOB) and raises the price target from $26 to $28.

Portfolio Pulse from richadhand@benzinga.com

June 29, 2023 | 3:37 pm

IBTX

Truist Securities analyst Brandon King maintains a 'Buy' rating on Independent Bank Gr (NASDAQ:IBTX), but has lowered the price target from $43 to $40.

Portfolio Pulse from richadhand@benzinga.com

June 29, 2023 | 3:36 pm

BNTX

BioNTech Inc.'s (NASDAQ:BNTX) shares are currently trading at $107.16, after a 0.24% increase. Over the past month, the stock has risen by 2.91%, but it has decreased by 31.97% over the past year. The company's P/E ratio of 3.81 is lower than the Biotechnology industry average of 50.29, which could indicate that the stock is undervalued or that shareholders do not expect future growth.

Portfolio Pulse from Benzinga Insights

June 29, 2023 | 3:33 pm

DIS

MU

NPWR

OPK

PFE

WING

Benzinga has released its top ratings upgrades, downgrades, and initiations for June 29, 2023. Upgrades include OPKO Health Inc, The RealReal Inc, Schneider National Inc, Intercept Pharmaceuticals Inc, FREYR Battery, Paramount Resources Ltd, and Micron Technology Inc. Downgrades include Symbotic Inc, Ashland Inc, RH, ContextLogic Inc, Citizens Financial Group Inc, Pfizer Inc, Inter & Co Inc, and The Walt Disney Co. New coverage initiations include NET Power Inc, Wingstop Inc, C3.ai Inc, Arlo Technologies Inc, CNO Financial Group Inc, Mister Car Wash Inc, Atlassian Corp, TJX Companies Inc, Ross Stores Inc, Instil Bio Inc, Establishment Labs Holdings Inc, Warner Music Group Corp, Corebridge Financial Inc, Generac Holdings Inc, Banco Latinoamericano de Comercio Exterior SA, Unity Software Inc, Academy Sports and Outdoors Inc, Hibbett Inc, Clarus Corp, Fox Factory Holding Corp, Quest Diagnostics Inc, Burlington Stores Inc, Freeport-McMoRan Inc, Tenaris SA, Roku Inc, Pentair PLC, Zurn Elkay Water Solutions Corp, Badger Meter Inc, Xylem Inc, and Gold Royalty Corp.

Portfolio Pulse from Benzinga Insights

June 29, 2023 | 3:02 pm

FWBI

Over the past three months, five analysts have given bullish ratings to First Wave BioPharma (NASDAQ:FWBI) with an average price target of $11.6, a decrease of 27.5% from the previous average price target of $16.00. No bearish or neutral ratings were reported.

Portfolio Pulse from Benzinga Insights

June 29, 2023 | 3:01 pm

BMI

In the last quarter, Badger Meter (NYSE:BMI) received 2 bullish and 5 indifferent analyst ratings. The average 12-month price target for the company, according to 7 analysts, is $131.43, an increase of 11.54% from the previous average of $117.83. No bearish ratings were observed.

Portfolio Pulse from Benzinga Insights

June 29, 2023 | 3:01 pm

ASH

Ashland (NYSE:ASH) has received various analyst ratings in the last quarter, with 5 bullish, 2 somewhat bullish, and 3 indifferent. The average 12-month price target for Ashland, according to 10 analysts, is $115.0, representing a 7.76% decrease from the previous average price target of $124.67.

Portfolio Pulse from Benzinga Insights

June 29, 2023 | 3:00 pm

CMA

Over the last quarter, Comerica (NYSE:CMA) has received 7 bullish, 5 somewhat bullish, 4 indifferent, and 2 somewhat bearish ratings from 18 analysts. The average price target is $55.51, indicating an upside from the current price of $43.22. However, this average has decreased by 22.05% from the previous average price target of $71.21.

Portfolio Pulse from Benzinga Insights

June 29, 2023 | 3:00 pm

RH

In the last quarter, RH (NYSE:RH) has received a mix of analyst ratings, with 1 bullish, 2 somewhat bullish, 7 indifferent, and 1 bearish. The average 12-month price target for the company is $260.18, a decrease of 0.48% from the previous average of $261.43.

Portfolio Pulse from Benzinga Insights

June 29, 2023 | 3:00 pm

COST

In the last quarter, Costco Wholesale (NASDAQ:COST) received mostly bullish ratings from analysts, with 5 being bullish and 9 somewhat bullish. The company has an average 12-month price target of $551.27, which has increased by 1.55% over the past month.

Portfolio Pulse from Benzinga Insights

June 29, 2023 | 3:00 pm